Found: 23
Select item for more details and to access through your institution.
MZ1 co-operates with trastuzumab in HER2 positive breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01907-9
- By:
- Publication type:
- Article
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 10, p. 5476, doi. 10.3390/ijms23105476
- By:
- Publication type:
- Article
Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 8, p. 3836, doi. 10.3390/ijms22083836
- By:
- Publication type:
- Article
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 23, p. 9034, doi. 10.3390/ijms21239034
- By:
- Publication type:
- Article
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. 1, doi. 10.1186/s13046-019-1387-5
- By:
- Publication type:
- Article
Clinical considerations for the design of PROTACs in cancer.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01535-7
- By:
- Publication type:
- Article
Neutrophils in cancer: prognostic role and therapeutic strategies.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0707-7
- By:
- Publication type:
- Article
Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal–Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3250, doi. 10.3390/cancers15123250
- By:
- Publication type:
- Article
Uncovering therapeutic opportunities in the clinical development of antibody‐drug conjugates.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 9, p. 1, doi. 10.1002/ctm2.1329
- By:
- Publication type:
- Article
Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 5, p. 3117, doi. 10.1111/jcmm.14980
- By:
- Publication type:
- Article
Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01519-0
- By:
- Publication type:
- Article
Mapping Bromodomains in breast cancer and association with clinical outcome.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-41934-3
- By:
- Publication type:
- Article
Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1432015
- By:
- Publication type:
- Article
Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
- Published in:
- Cellular Oncology (2211-3428), 2020, v. 43, n. 3, p. 431, doi. 10.1007/s13402-020-00497-6
- By:
- Publication type:
- Article
Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0209134
- By:
- Publication type:
- Article
Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0207776
- By:
- Publication type:
- Article
Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5345, doi. 10.3390/ijms25105345
- By:
- Publication type:
- Article
In Silico Transcriptomic Expression of MSR1 in Solid Tumors Is Associated with Responses to Anti-PD1 and Anti-CTLA4 Therapies.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3987, doi. 10.3390/ijms25073987
- By:
- Publication type:
- Article
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2222, doi. 10.3390/ijms25042222
- By:
- Publication type:
- Article
Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 18, p. 13820, doi. 10.3390/ijms241813820
- By:
- Publication type:
- Article
Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer.
- Published in:
- Nanomaterials (2079-4991), 2019, v. 9, n. 12, p. 1793, doi. 10.3390/nano9121793
- By:
- Publication type:
- Article
Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy.
- Published in:
- Nanomaterials (2079-4991), 2019, v. 9, n. 9, p. 1208, doi. 10.3390/nano9091208
- By:
- Publication type:
- Article
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers.
- Published in:
- Current Oncology, 2023, v. 30, n. 3, p. 2569, doi. 10.3390/curroncol30030196
- By:
- Publication type:
- Article